Thalidomide treatment in cutaneous lesions of systemic lupus erythematosus: a multicenter study in China-Reference-Cited by-同舟云学术

Thalidomide treatment in cutaneous lesions of systemic lupus erythematosus: a multicenter study in China

Published:2016-04-21 Issue:6 Volume:35 Page:1521-1527
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Wang Dandan,Chen Haifeng,Wang Shiying,Zou Yaohong,Li Jing,Pan Jieping,Wang Xiangdang,Ren Tianli,Zhang Yu,Chen Zhiwei,Feng Xuebing,Sun Lingyun

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s10067-016-3256-3.pdf

Reference36 articles.

1. Sheskin J (1965) Thalidomide in the treatment of lepra reactions. Clin Pharmacol Ther 6:303–306

2. Doherty SD, Hsu S (2008) A case series of 48 patients treated with thalidomide. J Drugs Dermatol 7(8):769–773

3. Gutiérrez-Rodriguez O, Starusta-Bacal P, Gutiérrez-Montes O (1989) Treatment of rheumatoid arthritis: the thalidomide experience. J Rheumatol 16(2):158–163

4. Hamuryudan V, Mat C, Saip S et al (1998) Thalidomide in the treatment of the mucocutaneous lesions of Behcet’s syndrome: a randomised, double-blind, placebo controlled trial. Ann Intern Med 128(6):443–459

5. Barlogie B, Desikan R, Eddlemon P et al (2001) Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients. Blood 98(2):492–494

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Specialized and niche therapies;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Efficacy and safety of thalidomide in children with monogenic autoinflammatory diseases: a single-center, real-world-evidence study;Pediatric Rheumatology;2023-10-17

3. An update on the management of refractory cutaneous lupus erythematosus;Frontiers in Medicine;2022-09-23

4. Thalidomide and discoid lupus erythematosus: case series and review of literature;Drugs in Context;2022-03-16

5. Lupus Vasculitis: An Overview;Biomedicines;2021-11-05